nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB10—head—cleft lip	0.00399	0.148	CbGeAlD
Carfilzomib—PSMB1—embryo—cleft lip	0.00392	0.145	CbGeAlD
Carfilzomib—PSMB2—embryo—cleft lip	0.00383	0.142	CbGeAlD
Carfilzomib—PSMB5—telencephalon—cleft lip	0.00365	0.135	CbGeAlD
Carfilzomib—PSMB1—telencephalon—cleft lip	0.00319	0.118	CbGeAlD
Carfilzomib—PSMB2—telencephalon—cleft lip	0.00311	0.115	CbGeAlD
Carfilzomib—PSMB1—head—cleft lip	0.00199	0.0736	CbGeAlD
Carfilzomib—PSMB2—head—cleft lip	0.00194	0.0718	CbGeAlD
Carfilzomib—PSMB10—Immune System—FGF10—cleft lip	0.000679	0.000697	CbGpPWpGaD
Carfilzomib—PSMB8—TCF dependent signaling in response to WNT—MYC—cleft lip	0.000677	0.000696	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—MTR—cleft lip	0.000675	0.000694	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—FGF10—cleft lip	0.000675	0.000694	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling by Wnt—MYC—cleft lip	0.000672	0.00069	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—FGFR2—cleft lip	0.000671	0.000689	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling by Wnt—MYC—cleft lip	0.000669	0.000687	CbGpPWpGaD
Carfilzomib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—cleft lip	0.000667	0.000686	CbGpPWpGaD
Carfilzomib—PSMB2—RNF mutants show enhanced WNT signaling and proliferation—MYC—cleft lip	0.000665	0.000684	CbGpPWpGaD
Carfilzomib—PSMB5—RNF mutants show enhanced WNT signaling and proliferation—MYC—cleft lip	0.000665	0.000684	CbGpPWpGaD
Carfilzomib—PSMB1—RNF mutants show enhanced WNT signaling and proliferation—MYC—cleft lip	0.000665	0.000684	CbGpPWpGaD
Carfilzomib—PSMB8—RNF mutants show enhanced WNT signaling and proliferation—MYC—cleft lip	0.000656	0.000674	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGF8—cleft lip	0.000655	0.000674	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGF8—cleft lip	0.000652	0.00067	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—FGFR1—cleft lip	0.000634	0.000652	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—FGFR1—cleft lip	0.000634	0.000652	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—FGFR1—cleft lip	0.000634	0.000652	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—FGF10—cleft lip	0.000627	0.000644	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FGF3—cleft lip	0.000625	0.000643	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FGF3—cleft lip	0.000625	0.000643	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FGF3—cleft lip	0.000625	0.000643	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—FGFR1—cleft lip	0.000625	0.000643	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—FGF10—cleft lip	0.000624	0.000641	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by WNT in cancer—MYC—cleft lip	0.000618	0.000635	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by WNT in cancer—MYC—cleft lip	0.000618	0.000635	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by WNT in cancer—MYC—cleft lip	0.000618	0.000635	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FGF3—cleft lip	0.000617	0.000634	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—FGF2—cleft lip	0.000611	0.000628	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FGF9—cleft lip	0.00061	0.000627	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FGF9—cleft lip	0.00061	0.000627	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FGF9—cleft lip	0.00061	0.000627	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by WNT in cancer—MYC—cleft lip	0.000609	0.000626	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—FGF2—cleft lip	0.000608	0.000625	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FGF9—cleft lip	0.000601	0.000618	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—FGFR3—cleft lip	0.000599	0.000616	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—FGFR3—cleft lip	0.000599	0.000616	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—FGFR3—cleft lip	0.000599	0.000616	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—FGFR3—cleft lip	0.000591	0.000607	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PTCH1—cleft lip	0.000588	0.000605	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PTCH1—cleft lip	0.000586	0.000602	CbGpPWpGaD
Carfilzomib—ABCB1—embryo—cleft lip	0.000585	0.0217	CbGeAlD
Carfilzomib—PSMB5—Disease—FGF3—cleft lip	0.000577	0.000593	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—FGF3—cleft lip	0.000577	0.000593	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—FGF3—cleft lip	0.000577	0.000593	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—MTR—cleft lip	0.000574	0.00059	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—MTR—cleft lip	0.000574	0.00059	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—MTR—cleft lip	0.000574	0.00059	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—FGF3—cleft lip	0.000569	0.000585	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—MTR—cleft lip	0.000566	0.000581	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—FGF9—cleft lip	0.000563	0.000579	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—FGF9—cleft lip	0.000563	0.000579	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—FGF9—cleft lip	0.000563	0.000579	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000556	0.000572	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—FGF9—cleft lip	0.000555	0.00057	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—FGFR2—cleft lip	0.000545	0.00056	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—FGFR2—cleft lip	0.000542	0.000557	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SPRY2—cleft lip	0.000538	0.000553	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SPRY2—cleft lip	0.000538	0.000553	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SPRY2—cleft lip	0.000538	0.000553	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGF7—cleft lip	0.000538	0.000553	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGF7—cleft lip	0.000538	0.000553	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGF7—cleft lip	0.000538	0.000553	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGF3—cleft lip	0.000533	0.000548	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGF3—cleft lip	0.000531	0.000546	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGF7—cleft lip	0.000531	0.000545	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SPRY2—cleft lip	0.000531	0.000545	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGF9—cleft lip	0.00052	0.000535	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGF9—cleft lip	0.000518	0.000532	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FGF10—cleft lip	0.000514	0.000529	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FGF10—cleft lip	0.000514	0.000529	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FGF10—cleft lip	0.000514	0.000529	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by Wnt—MYC—cleft lip	0.000509	0.000523	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by Wnt—MYC—cleft lip	0.000509	0.000523	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by Wnt—MYC—cleft lip	0.000509	0.000523	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—FGFR1—cleft lip	0.000508	0.000522	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FGF10—cleft lip	0.000507	0.000521	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—FGFR1—cleft lip	0.000505	0.000519	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—FGFR2—cleft lip	0.000503	0.000517	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by Wnt—MYC—cleft lip	0.000502	0.000516	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—FGFR2—cleft lip	0.0005	0.000514	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGF8—cleft lip	0.000497	0.00051	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGF8—cleft lip	0.000497	0.00051	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGF8—cleft lip	0.000497	0.00051	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGF8—cleft lip	0.00049	0.000503	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle, Mitotic—MYC—cleft lip	0.000488	0.000501	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle, Mitotic—MYC—cleft lip	0.000485	0.000499	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—MTHFR—cleft lip	0.000484	0.000497	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—MTHFR—cleft lip	0.000482	0.000495	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—FGFR3—cleft lip	0.00048	0.000493	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—FGFR3—cleft lip	0.000477	0.000491	CbGpPWpGaD
Carfilzomib—ABCB1—telencephalon—cleft lip	0.000475	0.0176	CbGeAlD
Carfilzomib—PSMB5—Disease—FGF10—cleft lip	0.000475	0.000488	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—FGF10—cleft lip	0.000475	0.000488	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—FGF10—cleft lip	0.000475	0.000488	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000471	0.000484	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—FGFR1—cleft lip	0.000469	0.000482	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—FGF10—cleft lip	0.000468	0.000481	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—FGFR1—cleft lip	0.000466	0.000479	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—TYMS—cleft lip	0.000464	0.000477	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—FGF2—cleft lip	0.000463	0.000476	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—FGF2—cleft lip	0.000463	0.000476	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—FGF2—cleft lip	0.000463	0.000476	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—TYMS—cleft lip	0.000462	0.000475	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—FGF2—cleft lip	0.000457	0.000469	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PTCH1—cleft lip	0.000446	0.000458	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PTCH1—cleft lip	0.000446	0.000458	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PTCH1—cleft lip	0.000446	0.000458	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—FGFR3—cleft lip	0.000443	0.000455	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—FGFR3—cleft lip	0.000441	0.000453	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PTCH1—cleft lip	0.00044	0.000452	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGF10—cleft lip	0.000439	0.000451	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGF10—cleft lip	0.000437	0.000449	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—MYC—cleft lip	0.000436	0.000448	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—MYC—cleft lip	0.000434	0.000446	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FGFR2—cleft lip	0.000413	0.000424	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FGFR2—cleft lip	0.000413	0.000424	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FGFR2—cleft lip	0.000413	0.000424	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FGFR2—cleft lip	0.000407	0.000418	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—MTHFR—cleft lip	0.000405	0.000417	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGF3—cleft lip	0.000404	0.000416	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGF3—cleft lip	0.000404	0.000416	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGF3—cleft lip	0.000404	0.000416	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—MTHFR—cleft lip	0.000403	0.000415	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGF3—cleft lip	0.000399	0.00041	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGF9—cleft lip	0.000394	0.000405	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGF9—cleft lip	0.000394	0.000405	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGF9—cleft lip	0.000394	0.000405	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGF9—cleft lip	0.000389	0.000399	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FGFR1—cleft lip	0.000385	0.000395	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FGFR1—cleft lip	0.000385	0.000395	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FGFR1—cleft lip	0.000385	0.000395	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—FGFR2—cleft lip	0.000381	0.000392	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—FGFR2—cleft lip	0.000381	0.000392	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—FGFR2—cleft lip	0.000381	0.000392	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FGFR1—cleft lip	0.000379	0.00039	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—FGFR2—cleft lip	0.000376	0.000386	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—FGF2—cleft lip	0.000371	0.000381	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle, Mitotic—MYC—cleft lip	0.00037	0.00038	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle, Mitotic—MYC—cleft lip	0.00037	0.00038	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle, Mitotic—MYC—cleft lip	0.00037	0.00038	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—FGF2—cleft lip	0.000369	0.000379	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—MTHFR—cleft lip	0.000367	0.000377	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—MTHFR—cleft lip	0.000367	0.000377	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—MTHFR—cleft lip	0.000367	0.000377	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle, Mitotic—MYC—cleft lip	0.000364	0.000375	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FGFR3—cleft lip	0.000364	0.000374	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FGFR3—cleft lip	0.000364	0.000374	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FGFR3—cleft lip	0.000364	0.000374	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—MTHFR—cleft lip	0.000362	0.000372	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FGFR3—cleft lip	0.000358	0.000368	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—FGFR1—cleft lip	0.000355	0.000365	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—FGFR1—cleft lip	0.000355	0.000365	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—FGFR1—cleft lip	0.000355	0.000365	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGFR2—cleft lip	0.000352	0.000362	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—TYMS—cleft lip	0.000352	0.000361	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—TYMS—cleft lip	0.000352	0.000361	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—TYMS—cleft lip	0.000352	0.000361	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGFR2—cleft lip	0.00035	0.00036	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—FGFR1—cleft lip	0.00035	0.00036	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—TYMS—cleft lip	0.000347	0.000356	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000344	0.000353	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—FGF2—cleft lip	0.000342	0.000352	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—FGF2—cleft lip	0.000341	0.00035	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—NOS3—cleft lip	0.000338	0.000347	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—NOS3—cleft lip	0.000336	0.000345	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—FGFR3—cleft lip	0.000336	0.000345	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—FGFR3—cleft lip	0.000336	0.000345	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—FGFR3—cleft lip	0.000336	0.000345	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGF10—cleft lip	0.000333	0.000342	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGF10—cleft lip	0.000333	0.000342	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGF10—cleft lip	0.000333	0.000342	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—FGFR3—cleft lip	0.000331	0.00034	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—MYC—cleft lip	0.000331	0.00034	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—MYC—cleft lip	0.000331	0.00034	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—MYC—cleft lip	0.000331	0.00034	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGFR1—cleft lip	0.000328	0.000337	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGF10—cleft lip	0.000328	0.000337	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGFR1—cleft lip	0.000327	0.000336	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—MYC—cleft lip	0.000326	0.000335	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGFR3—cleft lip	0.00031	0.000319	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGFR3—cleft lip	0.000309	0.000317	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—MTHFR—cleft lip	0.000307	0.000316	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—MTHFR—cleft lip	0.000307	0.000316	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—MTHFR—cleft lip	0.000307	0.000316	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—MTHFR—cleft lip	0.000303	0.000311	CbGpPWpGaD
Carfilzomib—ABCB1—head—cleft lip	0.000296	0.011	CbGeAlD
Carfilzomib—ABCB1—Metabolism—SLC19A1—cleft lip	0.000294	0.000302	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—NOS3—cleft lip	0.000283	0.000291	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—NOS3—cleft lip	0.000281	0.000289	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FGF2—cleft lip	0.000281	0.000289	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FGF2—cleft lip	0.000281	0.000289	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FGF2—cleft lip	0.000281	0.000289	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FGF2—cleft lip	0.000277	0.000285	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGFR2—cleft lip	0.000267	0.000274	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGFR2—cleft lip	0.000267	0.000274	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGFR2—cleft lip	0.000267	0.000274	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGFR2—cleft lip	0.000263	0.00027	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—FGF2—cleft lip	0.000259	0.000267	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—FGF2—cleft lip	0.000259	0.000267	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—FGF2—cleft lip	0.000259	0.000267	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NOS3—cleft lip	0.000256	0.000263	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NOS3—cleft lip	0.000256	0.000263	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NOS3—cleft lip	0.000256	0.000263	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—FGF2—cleft lip	0.000256	0.000263	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NOS3—cleft lip	0.000252	0.000259	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGFR1—cleft lip	0.000249	0.000256	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGFR1—cleft lip	0.000249	0.000256	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGFR1—cleft lip	0.000249	0.000256	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGFR1—cleft lip	0.000245	0.000252	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TCN2—cleft lip	0.000243	0.00025	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—MYC—cleft lip	0.000241	0.000248	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—MYC—cleft lip	0.00024	0.000246	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGF2—cleft lip	0.00024	0.000246	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGF2—cleft lip	0.000239	0.000245	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NOS3—cleft lip	0.000236	0.000243	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NOS3—cleft lip	0.000235	0.000242	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGFR3—cleft lip	0.000235	0.000242	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGFR3—cleft lip	0.000235	0.000242	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGFR3—cleft lip	0.000235	0.000242	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGFR3—cleft lip	0.000232	0.000238	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000225	0.000231	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—MYC—cleft lip	0.000224	0.00023	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—MYC—cleft lip	0.000223	0.000229	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NOS3—cleft lip	0.000214	0.00022	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NOS3—cleft lip	0.000214	0.00022	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NOS3—cleft lip	0.000214	0.00022	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NOS3—cleft lip	0.000211	0.000217	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—MYC—cleft lip	0.000183	0.000188	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—MYC—cleft lip	0.000183	0.000188	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—MYC—cleft lip	0.000183	0.000188	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGF2—cleft lip	0.000182	0.000187	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGF2—cleft lip	0.000182	0.000187	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGF2—cleft lip	0.000182	0.000187	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—MYC—cleft lip	0.00018	0.000185	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NOS3—cleft lip	0.000179	0.000184	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NOS3—cleft lip	0.000179	0.000184	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NOS3—cleft lip	0.000179	0.000184	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGF2—cleft lip	0.000179	0.000184	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NOS3—cleft lip	0.000177	0.000182	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—MYC—cleft lip	0.00017	0.000174	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—MYC—cleft lip	0.00017	0.000174	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—MYC—cleft lip	0.00017	0.000174	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MTR—cleft lip	0.000169	0.000173	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—MYC—cleft lip	0.000167	0.000172	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MYC—cleft lip	0.000157	0.000161	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MYC—cleft lip	0.000156	0.00016	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MYC—cleft lip	0.000119	0.000122	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MYC—cleft lip	0.000119	0.000122	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MYC—cleft lip	0.000119	0.000122	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MYC—cleft lip	0.000117	0.00012	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TYMS—cleft lip	0.000103	0.000106	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MTHFR—cleft lip	9.04e-05	9.29e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NOS3—cleft lip	6.3e-05	6.48e-05	CbGpPWpGaD
